Related Experiment Video
Updated: Nov 6, 2025

09:10
Murine Salivary Functional Assessment via Pilocarpine Stimulation Following Fractionated Radiation
Published on: May 4, 2018
11.7K
Salivary caffeine in Parkinson's disease
Giorgio Leodori1,2, Maria Ilenia De Bartolo1, Daniele Belvisi1,2
1IRCCS NEUROMED, Via Atinense, 18, 86077, Pozzilli, Italy.
Scientific Reports
|May 11, 2021
Summary
Salivary caffeine levels are decreased in moderate/advanced Parkinson's disease (PD) patients, correlating with disease severity. Caffeine absorption and metabolism remain normal in PD, suggesting salivary caffeine may indicate disease progression.
Area of Science:
- Neuroscience
- Pharmacology
- Biomarker Research
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder.
- Investigating potential biomarkers for PD diagnosis and progression is crucial.
- Salivary caffeine levels have not been extensively studied in relation to PD.
Purpose of the Study:
- To investigate salivary caffeine content, absorption, and metabolism in Parkinson's disease (PD) patients.
- To determine if salivary caffeine can serve as a biomarker for PD.
- To correlate salivary caffeine levels with PD severity and clinical features.
Main Methods:
- Salivary caffeine and paraxanthine levels were measured in 98 PD patients and 92 healthy controls before and after oral caffeine intake.
- Caffeine absorption and metabolism were quantified.
- Clinical assessments included the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III and Hoehn & Yahr staging.
Main Results:
- Salivary caffeine levels were decreased in moderate/advanced PD patients but normal in early/de-novo PD.
- Caffeine absorption and metabolism were not significantly different between PD patients and controls.
- Decreased salivary caffeine levels correlated with higher disease severity, longer duration, and motor complications.
Conclusions:
- Salivary caffeine levels decrease with Parkinson's disease progression.
- Salivary caffeine may serve as a potential, non-invasive biomarker for PD severity.
- Further research is warranted to validate salivary caffeine as a PD biomarker.
More Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
631
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
631
Parkinson's Disease: Overview
1.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.1K
Neural Regulation
40.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.9K
Salivary Glands and Saliva
1.3K
The salivary glands, of which there are three pairs known as the parotid, submandibular, and sublingual glands, play a crucial role in maintaining oral health and initiating the digestive process. Positioned near the ears, beneath the masseter muscle, the parotid glands secrete saliva into the oral cavity through the parotid duct of Stensen. Meanwhile, the submandibular glands, located on the floor of the mouth, secrete saliva through channels named submandibular ducts. The sublingual glands,...
1.3K

